CAR-T Cell Therapy Clinical Trials
3 recruiting trials for CAR-T Cell Therapy. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT07288879
DALY II Japan/MB-CART2019.1 for DLBCL
DALY II Japan is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with...
Sponsor: Miltenyi Biomedicine GmbHEnrolling: 315 locations
RECRUITINGPhase 1NCT06196294
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
The third generation of GPC3/mesothelin targeted CAR-γδT cells have been constructed and their anti-cancer function has been verified by multiple in vitro and in vivo studies....
Sponsor: Second Affiliated Hospital of Guangzhou Medical UniversityEnrolling: 301 location
RECRUITINGNCT06508346
Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV
This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-CD19 CAR-T cells in the treatment of childhood-onset refractory ANCA-Associated...
Sponsor: The Children's Hospital of Zhejiang University School of MedicineEnrolling: 121 location